Prevalence of Candidate Vaccine Targets and Genomic Features of Pediatric Invasive Streptococcus Agalactiae in Japan

Masashi Kasai1,2, Satoshi Nakano3,4, Shota Koide3

  • 1Division of Infectious Disease, Hyogo Prefectural Kobe Children's Hospital, Kobe, Japan.

PubMed

Insights

Genomic surveillance in Japan shows current Group B Streptococcus (GBS) vaccines could cover most pediatric invasive infections. Further research into transmission routes is crucial for future prevention strategies.

Area of Science:

  • Microbiology
  • Genomics
  • Epidemiology

Background:

  • Group B Streptococcus (GBS) causes severe neonatal and infant infections like sepsis and meningitis.
  • Despite antibiotic prophylaxis, GBS remains a significant public health issue.
  • This study addresses GBS in Japan, focusing on pediatric invasive infections.

Purpose of the Study:

  • Estimate vaccine coverage for pediatric invasive GBS in Japan.
  • Characterize the genomic epidemiology of invasive GBS isolates.
  • Inform future prevention strategies for GBS infections.

Main Methods:

  • Nationwide, multicenter, retrospective genomic surveillance.
  • Analysis of 237 GBS isolates from children (≤15 years) in Japan (2004-2023).
  • Serotyping, antimicrobial susceptibility testing, whole-genome sequencing, and phylogenetic/SNP analyses were performed.

Main Results:

  • Serotype III was most common (48.1%), followed by Ia (27.4%) and Ib (12.2%).
  • Estimated vaccine coverage: 98.3% (hexavalent polysaccharide), 94.9% (GBS-NN/NN2 protein).
  • High resistance to erythromycin (61.2%) and clindamycin (43.5%); penicillin susceptibility maintained. Dominance of a multidrug-resistant CC17 clone identified. Evidence of nosocomial transmission and regional circulation within ST17 and ST23 lineages.

Conclusions:

  • Current maternal GBS vaccine candidates show potential for broad coverage against pediatric invasive infections in Japan.
  • Persistent and regionally disseminated lineages necessitate investigation of transmission routes, including environmental reservoirs.
  • Genomic data is vital for developing effective future GBS prevention strategies.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.2K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.5K
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.6K